Maryland Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.

Press releases published on September 14, 2026

Sep. 14, 2026

Kelly Nuckolls Is a Finalist for CRN’s 2026 Women of the Year Awards

Indeterminate EIN Presswire

Sep. 14, 2026

Lentech Names Ryan Rohr Chief Growth Officer to Lead Next Phase of Growth

Indeterminate EIN Presswire

Sep. 14, 2026

Questor Announces Resignation of Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 14, 2026

KnowledgeRoots™ Media Center Debuts Deeply Rooted with Asha Peterson and Root Cause Business™

Indeterminate EIN Presswire

Sep. 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire

Sep. 14, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire

Sep. 14, 2026

What a Pharmacy Software Conversion Involves, From Data Migration to 90 Days of Support

Indeterminate GlobeNewswire

Sep. 14, 2026

Mike Tomlin to Keynote NC Central Basketball Tip-Off Banquet in First Fall Away From the Sideline

Indeterminate GlobeNewswire

Sep. 14, 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire

Sep. 14, 2026

Asha Peterson Launches KnowledgeRoots™ Media Center to Examine How Organizations Think, Operate, and Grow

Indeterminate EIN Presswire

Sep. 14, 2026

NowSecure Finds 1 in 4 Mobile Apps May Expose Functionality to AI Agents Ahead of iOS 27

Indeterminate GlobeNewswire

Sep. 14, 2026

Filmore Brings Construction Equipment Demand Into Microsoft Teams

Indeterminate GlobeNewswire

Sep. 14, 2026

Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health Platform

Indeterminate GlobeNewswire

Sep. 14, 2026

Robin van Poelje to Retire as CEO of Topicus.com Inc. on October 1, 2026; Board Names Ramon Zanders as his Successor

Indeterminate GlobeNewswire

Sep. 14, 2026

CloudOffix Successfully Completes SOC 2 Type I Examination

Indeterminate EIN Presswire

Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire

Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire

Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire

Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire